Back to search

Article

RIPK2 dictates insulin responses to tyrosine kinase inhibitors in obese mice

2020-04-05

Abstract excerpt

<h4>ABSTRACT</h4> Tyrosine kinase inhibitors (TKIs) used in cancer are also being investigated in diabetes. TKIs can improve blood glucose control in diabetic cancer patients, but the specific kinases that alter blood glucose or insulin are not clear. We sought to define the role of Receptor Interacting Serine/Threonine Kinase 2 (RIPK2) in mouse models of insulin resistance. We tested the TKI gefitinib, which inh...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c4beada3-6590-5597-ae66-d29dac5e4907
DOI
10.1101/2020.04.03.024620
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
RIPK2 dictates insulin responses to tyrosine kinase inhibitors in obese miceDOI 10.1101/2020.04.03.024620
Select a neighboring publication to make it the new centre.